Kaush Gandhi joins Euro RSCG Life Medicom as digital director
December 4, 2009Medical Communications appointment, medical communications, medicom
Euro RSCG Life Medicom has appointed Kaush Gandhi as digital director.A classically-trained marketer, formerly with Unilever and Wyeth, Kaush is …
Digital Pharma: Byte-sized roundup
December 4, 2009Medical Communications Abbott, GE Healthcare, HES, NICE, Twitter, digi, digital pharma
Last week it was the ABPI that joined Twitter this week it’s UK cost effectiveness watchdog
Genzyme resumes Cerezyme supplies
December 3, 2009Manufacturing and Production Cerezyme
Genzyme has begun shipping newly produced Cerezyme manufactured at its Allston Landing plant for the first time after it was …
Process R&D lab brings academia and industry together
December 3, 2009Research and Development Leeds, chemicals
A newly-opened laboratory at the University of Leeds in the UK will help support the development of ‘greener, cheaper and …
Boehringer prepares for diabetes launch
December 3, 2009Medical Communications Boehringer, DPP-4, diabetes
Boehringer Ingelheim has hired the London arm of international PR agency Weber Shandwick to handle the UK launch of its …
Call for Europe-wide innovation fund
December 3, 2009Research and Development Europe, biotech, finance
A new report on the state of biotech and pharmaceutical R&D in Europe says the sector is suffering from a …
LEC achieves IPA CPD Accreditation
December 3, 2009Medical Communications
As an IPA member since 2005, LEC has achieved IPA Continuous Professional Development (CPD) Accreditation for the second year running …
Professor Chris Ham to lead The King’s Fund from April, 2010
December 3, 2009Sales and Marketing UK, appointment, king's fund
Professor Chris Ham has been appointed new chief executive of UK health think tank The King’s Fund.Professor Ham, currently professor …
EU shake up for pharma
December 2, 2009Research and Development, Sales and Marketing Commission, Europe
Responsibility for pharma and biotech policy has been taken away from the European Commission’s Enterprise and Industry directorate and handed to the …
Tamsin Tierney, director, Just Health PR
December 2, 2009Medical Communications appointment, just health pr, medical communications
Just Health PR has appointed Tamsin Tierney to the newly created role of director.Tamsin was previously at Hill & Knowlton …
Digital Pharma: Pfizer launches European YouTube channel
December 2, 2009Medical Communications, Sales and Marketing Pfizer, digi, digital pharma, youtube
Pfizer has set up a YouTube channel to promote its European operations by showcasing some of its people.In one sequence …
Bayer takes Alzheimer’s diagnostic into pivotal trials
December 2, 2009Research and Development Alz, Bayer, diagnostic
An imaging agent that can detect amyloid plaques in the brains of Alzheimer’s patients and so may provide an accurate …
Adapt or die
December 2, 2009Manufacturing and Production competition, generics, industry, pa consulting
For years, healthcare has been one of the most profitable sectors in industry. However the world is changing, and fast.Generics …
Oxford BioTherapeutics appoints Dr Jim Cornett, Dr Jon Terrett and Dr Mike Gresser
December 2, 2009Research and Development Oxford Biotherapeutics, appointment, research and development
Oxford BioTherapeutics has expanded its US operations, recruiting a number of senior industry leaders.Dr Jim Cornett will head up operations …
New deal supports French pharma and biotech
December 1, 2009Research and Development, Sales and Marketing France, biotech
The French government has agreed a new deal with industry leaders to help the country’s pharma and biotech industries.President Sarkozy …
PPD buys BioDuro to get bigger in China
December 1, 2009Research and Development CRO, China, em
Pharmaceutical Product Development (PPD) has expanded its capacity to offer drug development services in Asia once again with the acquisition …
Building value – is the pipeline all that matters?
December 1, 2009Research and Development Les Rose, biotech, venture capital
Venture capital is a curious business and the global financial crisis in which we find ourselves has exposed some rather …
Incyte’s Novartis cancer drug deal could be worth $1bn
December 1, 2009Research and Development Incyte, Novartis
Novartis has paid Incyte Corporation $150 million up front for the rights to two oral investigational hematology-oncology therapies.The first is …
Shire files for Gaucher drug in Europe
December 1, 2009Sales and Marketing Cerezyme, Gaucher, Shire
Shire has followed up its marketing applications for Gaucher disease treatment velaglucerase alfa in the US and Canada with a …
UK faces north/south divide on cancer
December 1, 2009Sales and Marketing Cancer, NHS
There is a marked north/south divide when it comes to cancer patients’ chances of recovery, according to new statistics. The …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
